Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-081932

Chief Business Officer acquired 1,994 shares (grant or award)

  • Chief Business Officer gave up 651 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2025-06-02 Grant or award +997 $71.68 $71,465 16,203 D
Robb Gary Charles Chief Business Officer 2025-06-02 Grant or award +997 17,200 D
Robb Gary Charles Chief Business Officer 2025-06-03 Shares withheld for taxes −651 $71.68 $46,664 16,549 D
Loading xslF345X05/ownership.xml…